Recombinant multi-species SEC23B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SEC23B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the SEC23 subfamily of the SEC23/SEC24 family, which is involved in vesicle trafficking. The encoded protein has similarity to yeast Sec23p component of COPII. COPII is the coat protein complex responsible for vesicle budding from the ER. The function of this gene product has been implicated in cargo selection and concentration. Multiple alternatively spliced transcript variants have been identified in this gene. [provided by RefSeq, Feb 2010]
The Alternative Names of target: CDA-II,CDAII,CDAN2,CWS7,HEMPAS,Protein transport protein Sec23B,SEC23-related protein B,SEC23B,Sec23b,hSec23B
Go
to SEC23B products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP3541-Ag-1/ GM-Tg-hg-IP3541-Ag-2 | Human SEC23B protein | Human |
| GM-Tg-rg-IP3541-Ag-1/ GM-Tg-rg-IP3541-Ag-2 | Rat SEC23B protein | Rat |
| GM-Tg-mg-IP3541-Ag-1/ GM-Tg-mg-IP3541-Ag-2 | Mouse SEC23B protein | Mouse |
| GM-Tg-cynog-IP3541-Ag-1/ GM-Tg-cynog-IP3541-Ag-2 | Cynomolgus/Rhesus macaque SEC23B protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP3541-Ag-1/ GM-Tg-felg-IP3541-Ag-2 | Feline SEC23B protein | Feline |
| GM-Tg-cang-IP3541-Ag-1/ GM-Tg-cang-IP3541-Ag-2 | Canine SEC23B protein | Canine |
| GM-Tg-bovg-IP3541-Ag-1/ GM-Tg-bovg-IP3541-Ag-2 | Bovine SEC23B protein | Bovine |
| GM-Tg-equg-IP3541-Ag-1/ GM-Tg-equg-IP3541-Ag-2 | Equine SEC23B protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP3541-Ag-1/ GM-Tg-hg-IP3541-Ag-2;
GM-Tg-rg-IP3541-Ag-1/ GM-Tg-rg-IP3541-Ag-2;
GM-Tg-mg-IP3541-Ag-1/ GM-Tg-mg-IP3541-Ag-2; GM-Tg-cynog-IP3541-Ag-1/ GM-Tg-cynog-IP3541-Ag-2; GM-Tg-felg-IP3541-Ag-1/ GM-Tg-felg-IP3541-Ag-2; GM-Tg-cang-IP3541-Ag-1/ GM-Tg-cang-IP3541-Ag-2; GM-Tg-bovg-IP3541-Ag-1/ GM-Tg-bovg-IP3541-Ag-2; GM-Tg-equg-IP3541-Ag-1/ GM-Tg-equg-IP3541-Ag-2 |
| Products Name | SEC23B protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SEC23B |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SEC23B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.